PHAT FY 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$620,000

Operating Income

-$172M

Net Income

-$198M

EPS (Diluted)

$-5.70

Cash Flow

Operating Cash Flow

-$147M

Free Cash Flow

-$148M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$165M

Total Liabilities

$240M

Stockholders' Equity

-$75M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$620,000	-$521,000	-19.0%
Operating Income	-$172M	-$135M	-27.7%
Net Income	-$198M	-$144M	-37.4%